Boxer Capital Management’s G1 Therapeutics GTHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
– Sell
-660,000
Closed -$24.5M – 31
2018
Q1
$24.5M Buy
660,000
+30,821
+5% +$822K 2.61% 14
2017
Q4
$12.5M Hold
629,179
– – 2.28% 13
2017
Q3
$15.7M Hold
629,179
– – 3.57% 9
2017
Q2
$11M Buy
+629,179
New +$11M 2.61% 11

Other funds holding GTHX

Boxer Capital Management's GTHX Position: Q2 2018 in Review

Boxer Capital Management sold out of G1 Therapeutics (GTHX) in Q2 2018, closing a stake of 660,000 shares — an estimated $24.5M sold.

Boxer Capital Management first reported a position in GTHX in Q2 2017 and held it in 4 quarters. The position peaked at $24.5M in Q1 2018. 95 funds tracked by Wall St. Rank hold GTHX as of Q2 2018.

  • Boxer Capital Management reported no remaining G1 Therapeutics position as of Q2 2018 after selling out during the quarter.
  • Boxer Capital Management sold 660,000 G1 Therapeutics shares in Q2 2018, an estimated $24.5M.
  • Boxer Capital Management first reported a position in G1 Therapeutics in Q2 2017 and held it in 4 quarters.
  • Boxer Capital Management's G1 Therapeutics position peaked at $24.5M in Q1 2018.
  • 95 funds tracked by Wall St. Rank held G1 Therapeutics as of Q2 2018.

Based on Boxer Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.